Contract W911NF11C0090
Lanzatech, Inc. · Department Of Defense · May 4, 2011
Lanzatech, Inc. was awarded a federal contract by Department Of Defense (Department Of The Army) on May 4, 2011 for $566,000 of work in research and development in biotechnology. Performance is in Roselle, IL. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses cost-plus contract pricing. The most recent modification was on August 10, 2011.
Contract details
- PIID
- W911NF11C0090
- Award type
- Dca
- Pricing
- Cost Plus Fixed Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541711 · Research And Development In Biotechnology
- Product / service
- R&D-Other R & D-Adv Dev
- Place of performance
- Roselle, IL
- First action
- May 4, 2011
- Latest action
- August 10, 2011
Description
SUPPLEMENTAL RESEARCH EFFORT AWARD
Modification timeline
-
August 10, 2011Mod P00001$100.0K
-
May 4, 2011Base awardRESEARCH CONTRACT AWARD RESEARCH PROPOSAL TITLED; "NOVEL, LOW COST ROUTE TO SYNTHETIC JP-8 FROM NON FOOD RESOURCES."$466.3K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bluehalo, Llc | Department Of Defense | November 4, 2025 | $0 |
| Bluehalo, Llc | Department Of Defense | November 4, 2025 | $0 |
| Bluehalo, Llc | Department Of Defense | November 4, 2025 | $3.00M |
| Inbios International Inc | Department Of Defense | September 22, 2025 | $25.66M |
| Dynport Vaccine Company Llc | Department Of Defense | September 12, 2025 | $117.63M |
| Westat, Inc. | Department Of Defense | August 28, 2025 | $22.21M |
Top contractors in NAICS 541711
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Alliance For Energy Innovation, Llc | 2 | $10.68B |
| 2 | Emergent Product Development Gaithersburg Inc. | 7 | $1.63B |
| 3 | Janssen Pharmaceuticals, Inc. | 2 | $1.05B |
| 4 | Regeneron Pharmaceuticals Inc | 4 | $1.01B |
| 5 | Siga Technologies, Inc. | 3 | $560.59M |
| 6 | Battelle National Biodefense Institute, Llc | 106 | $469.31M |
| 7 | Glaxosmithkline, Llc | 6 | $321.65M |
| 8 | Merck Sharp & Dohme Llc | 3 | $309.72M |
| 9 | Sri International | 130 | $258.61M |
| 10 | American Type Culture Collection | 7 | $243.18M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract W911NF11C0090?
Contract W911NF11C0090 is a federal contract awarded to Lanzatech, Inc. by Department Of Defense on May 4, 2011 for $566,000 of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY. It has been modified 1 time since the base award.
Who won contract W911NF11C0090?
Lanzatech, Inc. won contract W911NF11C0090 from Department Of Defense.
How much is contract W911NF11C0090 worth?
Contract W911NF11C0090 has obligated $566,000 to date.